TITLE

Ventricular Tachycardia and Sudden Cardiac Death

AUTHOR(S)
Koplan, Bruce A.; Stevenson, William G.
PUB. DATE
March 2009
SOURCE
Mayo Clinic Proceedings;Mar2009, Vol. 84 Issue 3, p289
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Ventricular tachycardia (VT), which most commonly occurs in patients with structural heart disease, can be associated with an increased risk of sudden death. The most common cause of ventricular fibrillation is acute coronary ischemia, whereas a myocardial scar from prior infarct is the most common cause of sustained monomorphic VT in patients with structural heart disease. More benign forms of idiopathic VT can also occur in the absence of structural heart disease. Treatment of VT involves both emergent management and prevention of recurrence with medical and device therapy. Appropriately selected patients who have experienced VT or those who are at risk of VT may be candidates for an implantable cardioverter-defibrillator. The left ventricular ejection fraction is most frequently used to stratify patients with either ischemic or nonischemic cardiomyopathy who are at risk of sudden death and may be candidates for a prophylactic defibrillator. Catheter ablation may also be an option for appropriately selected patients with many forms of VT. This article discusses the etiologies and management of VT and its association with sudden death.
ACCESSION #
37147242

 

Related Articles

  • Torsades de pointes. Dulak, Sally Beattie; Metules, Terri J. // RN;Oct2004, Vol. 67 Issue 10, p24ac1 

    Focuses on torsades de pointes, a lethal form of ventricular tachycardia. Polymorphic QRS complexes that appear to twist around the isoelectric line; Key to preventing sudden cardiac death.

  • Common Arrhythmias in Outpatient Practice. Larson, Lyle W. // Clinician Reviews;Jan2010, Vol. 20 Issue 1, p38 

    The article discusses the common arrhythmias encountered in clinical outpatient setting which include premature ventricular contractions, paroxysmal supraventricular tachycardia and nonsustained ventricular tachycardia. Management goals for arrhythmia include symptom eradication and prevention...

  • Cardiac Arrhythmias Auto Detection in an Electrocardiogram Using Computer-Aided Diagnosis Algorithm. Ji Ae Park; Seok min Hwang; Ji-Won Baek; Yoon Nyun Kim; Jong-Ha Lee // Applied Mechanics & Materials;2014, Issue 556-562, p2728 

    Supraventricular tachycardia (SVT) is the most common arrhythmia and can be found in not only heart disease patients, but also healthy persons. However, the occurrence of SVT in heart disease patients implies that the potential of the heart diseases worsening, and it causes cardiac arrest when...

  • PREDICTION AND PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE. Lane, Rebecca E.; Cowie, Martin R.; Chow, Anthony W. C. // Heart;May2005, Vol. 91 Issue 5, p674 

    The article focuses on the prediction and prevention of sudden cardiac death (SCD) in heart failure. The degeneration of monomorphic ventricular tachycardia into ventricular fibrillation accounts for the majority of sudden arrhythmic deaths. The implantable cardioverter-defibrillator (lCD) is...

  • Molecular Predictors of Drug-induced Prolongation of the QT Interval. Dilaveris, Polychronis E.; Stefanadis, Christodoulos I. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Apr2005, Vol. 3 Issue 2, p105 

    One of the most common causes of drug withdrawal from the market is the prolongation of the QT interval associated with polymorphic ventricular tachycardia or torsade de pointes (TdP) that can degenerate into ventricular fibrillation and sudden cardiac death. Cardiac and non-cardiac drugs...

  • Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. Kass, Robert S.; Moss, Arthur J. // Journal of Clinical Investigation;Sep2003, Vol. 112 Issue 6, p810 

    The congenital long QT syndrome is a rare disorder in which mutation carriers are at risk for polymorphic ventricular tachycardia and/or sudden cardiac death. Discovery and analysis of gene mutations associated with variants of this disorder have provided novel insight into mechanisms of cardiac...

  • Gene therapy for ventricular tachyarrhythmias. Donahue, J K // Gene Therapy;Jun2012, Vol. 19 Issue 6, p600 

    Cardiac arrest is the leading cause of death in the United States and other developed countries. Ventricular tachyarrhythmias are the most prominent cause of cardiac arrest, and patients with structural heart disease are at increased risk for these abnormal heart rhythms. Drug and device...

  • Intra-beat Scaling Properties of Cardiac Arrhythmias and Sudden Cardiac Death. Rodríguez, Eduardo; Lerma, Claudia; Echeverría, Juan C.; Alvarez-Ramirez, Jose // AIP Conference Proceedings;2/14/2008, Vol. 978 Issue 1, p87 

    We applied detrended fluctuation analysis (DFA) to characterize the intra-beat scaling dynamics of electrocardiographic (ECG) recordings from the PhysioNet Sudden Cardiac Death Holter Database. The main finding of this contribution is that, in such recordings involving different types of...

  • Do the spatial characteristics of myocardial scar tissue determine the risk of ventricular arrhythmias? Arenal, Ángel; Hernández, Jesus; Pérez-David, Esther; Rubio-Guivernau, José L.; Ledesma-Carbayo, Maria J.; Fernández-Avilés, Francisco // Cardiovascular Research;May2012, Vol. 94 Issue 2, p324 

    Sudden cardiac death is one of the main causes of mortality in patients with structural heart disease. Although an implantable cardioverter defibrillator significantly reduces the mortality rate, many patients never receive a shock. Identification of high-risk patients would reduce the costs...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics